Pylarify 135 doses
Ended Awarded Last action
- Contract number
- 36C25023F0064
- Awardee
-
Progenics Pharmaceuticals Inc. UEI YLYKVRPCTCR3 Part of Lantheus Holdings, Inc.
- Awarding agency
-
Veterans Integrated Service Network 10
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $582,505
Award facts
- Contract value 100% obligated
- $582,505.38 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Sterling, VA, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $101,037 | |
| Funding Only Action | $7,136 | |
| Original award | $474,332 |
About this award
Veterans Integrated Service Network 10 issued a delivery order to Progenics Pharmaceuticals Inc. on October 1, 2022, for 135 doses of PYLARIFY (piflufolastat F-18), a radiopharmaceutical diagnostic imaging agent, with a ceiling value of $582,505.38 and firm fixed-price terms.
The order was issued under the GSA Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). Place of performance is Sterling, VA. The order's ultimate completion date is September 30, 2023. Dosing price was $3,608.72 per dose effective January 1, 2023. The order was obligated to fund final invoices against the schedule contract.
Quick answers
Who was awarded contract 36C25023F0064?
36C25023F0064 was awarded to Progenics Pharmaceuticals Inc. by Veterans Integrated Service Network 10 (Veterans Health Administration) on October 1, 2022.
How much is contract 36C25023F0064 worth?
The government has obligated $582,505 on 36C25023F0064.
Is contract 36C25023F0064 an order under another contract?
Yes. 36C25023F0064 is a delivery order under 36F79719D0170, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C25023F0064 competed?
The extent of competition for 36C25023F0064 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award